Edition:
United States

Profile: TearLab Corp (TLB.TO)

TLB.TO on Toronto Stock Exchange

0.68CAD
5 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.68
Open
--
Day's High
--
Day's Low
--
Volume
200
Avg. Vol
2,318
52-wk High
$2.36
52-wk Low
$0.67

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Company Address

TearLab Corp

9980 Huennekens St Ste 100
SAN DIEGO   CA   92121-2968
P: +1858.7941400
F: +1302.6745266

Company Web Links